Healthcare provider profile · identity verified

Dixitkumar N Modi, MD

Allopathic & Osteopathic Physicians|Family Medicine · COCOA BEACH, FL · NPI 1124238506

Profile state: payments and partd Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

CMS Open Payments records show Dixitkumar N Modi, MD received $186.85 in general payments during 2025 across 4 reported records.

Phathom Pharmaceuticals, Inc. accounted for 63.5% of that reported general-payment amount.

The Open Payments records used for this analysis explicitly named 5 associated products.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported JARDIANCE as an associated drug or biological on 47708 records involving 23833 distinct recipient NPIs. Public Medicare Part D data also shows 142 claims for Jardiance by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported MOUNJARO as an associated drug or biological on 186719 records involving 66436 distinct recipient NPIs. Public Medicare Part D data also shows 56 claims for Mounjaro by this doctor in 2024.

Lilly USA, LLC reported payments to this doctor in 2025. Across the 2025 Open Payments General Payment records loaded for this analysis, that same reporting entity reported TRULICITY as an associated drug or biological on 71 records involving 57 distinct recipient NPIs. Public Medicare Part D data also shows 55 claims for Trulicity by this doctor in 2024.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

$186.85

4 reported records · 4 companies

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Who paid this doctor?

Companies in 2025 General Payments

Reported company	Canonical company	Amount	Share	Records	Year
Phathom Pharmaceuticals, Inc.	Unresolved — no canonical attribution shown	$118.59	63.5%	1	2025
Exact Sciences Corporation	Unresolved — no canonical attribution shown	$26.57	14.2%	1	2025
Lilly USA, LLC	Unresolved — no canonical attribution shown	$22.63	12.1%	1	2025
Amgen Inc.	Unresolved — no canonical attribution shown	$19.06	10.2%	1	2025

What were the payments for?

Payment categories

Category	Amount	Records
Food and Beverage	$186.85	4

A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.

Analysis 1 · Payment-linked products

Products named in Open Payments records

Reported product	Type	Reported company	Related amount*	Records	Year
VOQUEZNA Normalized: voquezna	Drug	Phathom Pharmaceuticals, Inc.	$118.59	1	2025
Source payment records 2025-02-07 · Phathom Pharmaceuticals, Inc. · $118.59 · Open Payments source
Cologuard Collection Kit Normalized: cologuard collection kit	Device	Exact Sciences Corporation	$26.57	1	2025
Source payment records 2025-01-24 · Exact Sciences Corporation · $26.57 · Open Payments source
ZEPBOUND Normalized: zepbound	Drug	Lilly USA, LLC	$22.63	1	2025
Source payment records 2025-01-18 · Lilly USA, LLC · $22.63 · Open Payments source
OTEZLA Normalized: otezla	Drug	Amgen Inc.	$19.06	1	2025
Source payment records 2025-01-31 · Amgen Inc. · $19.06 · Open Payments source
REPATHA Normalized: repatha	Biological	Amgen Inc.	$19.06	1	2025
Source payment records 2025-01-31 · Amgen Inc. · $19.06 · Open Payments source

* Product-associated amounts are non-additive because one payment record may name more than one product.

These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.

Public prescribing for products named in payments

No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

Paying company	Payment year	Drug reported by same entity	Open Payments evidence	Part D	Claims	Beneficiaries
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	JARDIANCE open payments reported associated product	CMS Open Payments — General Payments 47708 supporting records · 23833 recipient NPIs · example record 1186464557	Jardiance · 2024 Exact normalized brand match · 1 Part D row	142	44
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	MOUNJARO open payments reported associated product	CMS Open Payments — General Payments 186719 supporting records · 66436 recipient NPIs · example record 1186464455	Mounjaro · 2024 Exact normalized brand match · 1 Part D row	56	suppressed by CMS
Lilly USA, LLC Exact reporting entity; no affiliate inference	2025	TRULICITY open payments reported associated product	CMS Open Payments — General Payments 71 supporting records · 57 recipient NPIs · example record 1186464601	Trulicity · 2024 Exact normalized brand match · 1 Part D row	55	11

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	821	238
Amlodipine Besylate	Amlodipine Besylate	737	225
Atorvastatin Calcium	Atorvastatin Calcium	736	229
Rosuvastatin Calcium	Rosuvastatin Calcium	727	220
Alprazolam	Alprazolam	631	134
Losartan Potassium	Losartan Potassium	623	199
Lisinopril	Lisinopril	602	183
Omeprazole	Omeprazole	400	137
Metoprolol Succinate	Metoprolol Succinate	377	114
Gabapentin	Gabapentin	347	105
Tamsulosin Hcl	Tamsulosin Hcl	277	92
Pantoprazole Sodium	Pantoprazole Sodium	273	91
Metformin Hcl	Metformin Hcl	272	82
Zolpidem Tartrate	Zolpidem Tartrate	267	83
Prednisone	Prednisone	248	191
Lorazepam	Lorazepam	246	49
Hydrochlorothiazide	Hydrochlorothiazide	240	78
Albuterol Sulfate Hfa	Albuterol Sulfate	237	97
Trazodone Hcl	Trazodone Hcl	220	69
Montelukast Sodium	Montelukast Sodium	207	65
Metformin Hcl Er	Metformin Hcl	201	58
Tramadol Hcl	Tramadol Hcl	196	95
Eliquis	Apixaban	189	49
Simvastatin	Simvastatin	182	58
Carvedilol	Carvedilol	179	65
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	163	38
Escitalopram Oxalate	Escitalopram Oxalate	161	46
Metoprolol Tartrate	Metoprolol Tartrate	151	53
Ozempic	Semaglutide	149	29
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	148	66
Allopurinol	Allopurinol	147	47
Jardiance	Empagliflozin	142	44
Sertraline Hcl	Sertraline Hcl	141	44
Clonazepam	Clonazepam	136	23
Duloxetine Hcl	Duloxetine Hcl	133	36
Citalopram Hbr	Citalopram Hydrobromide	127	39
Potassium Chloride	Potassium Chloride	124	45
Ezetimibe	Ezetimibe	123	40
Diazepam	Diazepam	121	29
Diclofenac Sodium	Diclofenac Sodium	121	38
Famotidine	Famotidine	119	45
Furosemide	Furosemide	119	48
Fluoxetine Hcl	Fluoxetine Hcl	116	37
Azithromycin	Azithromycin	113	101
Meloxicam	Meloxicam	111	35
Fluticasone Propionate	Fluticasone Propionate	108	47
Clopidogrel	Clopidogrel Bisulfate	106	34
Doxycycline Hyclate	Doxycycline Hyclate	106	94
Glipizide	Glipizide	103	26
Cephalexin	Cephalexin	99	84
Amoxicillin	Amoxicillin	97	86
Atenolol	Atenolol	96	31
Synthroid	Levothyroxine Sodium	94	27
Celecoxib	Celecoxib	93	31
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	89	28
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	88	26
Mirtazapine	Mirtazapine	88	35
Hydroxyzine Hcl	Hydroxyzine Hcl	87	22
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	82	30
Mometasone Furoate	Mometasone Furoate	81	38
Pravastatin Sodium	Pravastatin Sodium	80	25
Pregabalin	Pregabalin	78	15
Venlafaxine Hcl Er	Venlafaxine Hcl	78	20
Bupropion Xl	Bupropion Hcl	75	23
Finasteride	Finasteride	64	19
Alendronate Sodium	Alendronate Sodium	61	20
Mounjaro	Tirzepatide	56	suppressed
Temazepam	Temazepam	56	13
Trulicity	Dulaglutide	55	11
Hydralazine Hcl	Hydralazine Hcl	54	17
Isosorbide Mononitrate Er	Isosorbide Mononitrate	54	12
Dexlansoprazole Dr	Dexlansoprazole	53	12
Glimepiride	Glimepiride	51	16
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	51	15
Paroxetine Hcl	Paroxetine Hcl	50	15
Xarelto	Rivaroxaban	49	13
Abrysvo	Rsv Vacc, Pref A And Pref B/Pf	47	47
Quetiapine Fumarate	Quetiapine Fumarate	47	suppressed
Valsartan	Valsartan	47	15
Mupirocin	Mupirocin	46	38
Paxlovid	Nirmatrelvir/Ritonavir	46	45
Ropinirole Hcl	Ropinirole Hcl	45	11
Sildenafil Citrate	Sildenafil Citrate	45	11
Triamcinolone Acetonide	Triamcinolone Acetonide	45	34
Esomeprazole Magnesium	Esomeprazole Magnesium	44	12
Methocarbamol	Methocarbamol	43	13
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	42	39
Ibuprofen	Ibuprofen	41	18
Januvia	Sitagliptin Phosphate	41	11
Oxycodone Hcl	Oxycodone Hcl	41	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	40	suppressed
Tizanidine Hcl	Tizanidine Hcl	39	12
Testosterone Cypionate	Testosterone Cypionate	36	suppressed
Acyclovir	Acyclovir	35	18
Enalapril Maleate	Enalapril Maleate	35	suppressed
Lovastatin	Lovastatin	35	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	35	29
Clonidine Hcl	Clonidine Hcl	33	13
Fenofibrate	Fenofibrate Nanocrystallized	33	suppressed
Ipratropium Bromide	Ipratropium Bromide	33	suppressed
Tresiba Flextouch U-100	Insulin Degludec	33	suppressed
Glipizide Er	Glipizide	32	12
Propranolol Hcl	Propranolol Hcl	31	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	29	suppressed
Symbicort	Budesonide/Formoterol Fumarate	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	15
Warfarin Sodium	Warfarin Sodium	29	suppressed
Bumetanide	Bumetanide	28	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	28	12
Alcohol Pads	Alcohol Antiseptic Pads	27	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	27	suppressed
Azelastine Hcl	Azelastine Hcl	26	16
Benazepril Hcl	Benazepril Hcl	26	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Ondansetron Odt	Ondansetron	26	17
Bupropion Hcl Sr	Bupropion Hcl	25	12
Ciprofloxacin Hcl	Ciprofloxacin Hcl	25	23
Irbesartan	Irbesartan	25	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	24	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	24	suppressed
Entresto	Sacubitril/Valsartan	23	suppressed
Rabeprazole Sodium	Rabeprazole Sodium	23	suppressed
Aripiprazole	Aripiprazole	22	suppressed
Colchicine	Colchicine	22	suppressed
Folic Acid	Folic Acid	22	suppressed
Meclizine Hcl	Meclizine Hcl	22	12
Ramipril	Ramipril	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	22	suppressed
Fluconazole	Fluconazole	21	11
Linzess	Linaclotide	21	suppressed
Amlodipine-Atorvastatin	Amlodipine/Atorvastatin	20	suppressed
Repatha Sureclick	Evolocumab	20	suppressed
Donepezil Hcl	Donepezil Hcl	19	suppressed
Myrbetriq	Mirabegron	19	suppressed
Nifedipine Er	Nifedipine	19	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	19	16
Clindamycin Hcl	Clindamycin Hcl	18	18
Diphenoxylate-Atropine	Diphenoxylate Hcl/Atropine	18	suppressed
Estradiol	Estradiol	18	suppressed
Lamotrigine	Lamotrigine	18	suppressed
Levofloxacin	Levofloxacin	18	15
Naproxen	Naproxen	18	suppressed
Nystatin	Nystatin	18	11
Promethazine Hcl	Promethazine Hcl	18	11
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	17	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Chlorthalidone	Chlorthalidone	17	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	17	suppressed
Dutasteride	Dutasteride	17	suppressed
Amiodarone Hcl	Amiodarone Hcl	16	suppressed
Metronidazole	Metronidazole	16	16
Naproxen Sodium	Naproxen Sodium	16	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	16	suppressed
Spiriva Handihaler	Tiotropium Bromide	16	suppressed
Toprol Xl	Metoprolol Succinate	16	suppressed
Verapamil Er	Verapamil Hcl	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Eszopiclone	Eszopiclone	15	suppressed
Humalog Kwikpen U-100	Insulin Lispro	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Sotalol	Sotalol Hcl	15	suppressed
Sucralfate	Sucralfate	15	suppressed
Topiramate	Topiramate	15	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	14	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	14	11
Cilostazol	Cilostazol	14	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Ketoconazole	Ketoconazole	14	suppressed
Methotrexate	Methotrexate Sodium	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Pentoxifylline	Pentoxifylline	14	suppressed
Spironolactone	Spironolactone	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Benztropine Mesylate	Benztropine Mesylate	13	suppressed
Carbamazepine	Carbamazepine	13	suppressed
Lagevrio (Eua)	Molnupiravir	13	13
Tegretol	Carbamazepine	13	suppressed
Telmisartan	Telmisartan	13	suppressed
Wegovy	Semaglutide	13	suppressed
Ziprasidone Hcl	Ziprasidone Hcl	13	suppressed
Anastrozole	Anastrozole	12	suppressed
Clorazepate Dipotassium	Clorazepate Dipotassium	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Epinephrine	Epinephrine	12	suppressed
Fenofibrate	Fenofibrate,micronized	12	suppressed
Levetiracetam	Levetiracetam	12	suppressed
Nebivolol Hcl	Nebivolol Hcl	12	suppressed
Novofine 32	Pen Needle, Diabetic	12	suppressed
Boostrix Tdap	Diphth,pertuss(Acell),tet Vac	11	11
Gemfibrozil	Gemfibrozil	11	suppressed
Memantine Hcl	Memantine Hcl	11	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	11	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	11	suppressed
Ranolazine Er	Ranolazine	11	suppressed
Solifenacin Succinate	Solifenacin Succinate	11	suppressed
Ventolin Hfa	Albuterol Sulfate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	$186.85 · 4 records	Phathom Pharmaceuticals, Inc.	Cologuard Collection Kit, OTEZLA, REPATHA, VOQUEZNA, ZEPBOUND	3	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

How do you evaluate evidence when you have a financial relationship with Lilly USA, LLC?
Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error